Literature DB >> 15893934

Development of experimental designs for atherosclerosis studies in mice.

Alan Daugherty1, Debra L Rateri.   

Abstract

The mouse has become the de facto model for the majority of atherosclerosis studies. Studies involving the quantification of lesions in mouse models of the disease represent the basis of our evolving concepts on the biochemical and cellular mechanisms underlying the atherogenic process. Many issues of experimental design, including specific model, strain, gender, atherogenic stimulus, duration of study, group size, and statistical analysis may influence the outcome and interpretation of atherosclerosis studies. The selection of vascular bed in which to quantify atherosclerotic lesion size could also impact the interpretation of results. Early studies quantified atherosclerotic lesion size in either specific regions or all of the aortic sinus. Measurement of atherosclerosis throughout the aortic intimal surface has become a common mode for defining lesion size. It is likely that other vascular regions will be increasingly used. In addition to size, there is an increased emphasis on identifying and quantifying the cellular and chemical composition of atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893934     DOI: 10.1016/j.ymeth.2004.11.008

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  45 in total

1.  Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Venkateswaran Subramanian; Haruhito A Uchida; Talha Ijaz; Jessica J Moorleghen; Deborah A Howatt; Anju Balakrishnan
Journal:  J Cardiovasc Pharmacol       Date:  2012-01       Impact factor: 3.105

2.  FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells.

Authors:  Min Zhu; Qing-Jun Zhang; Lin Wang; Hao Li; Zhi-Ping Liu
Journal:  Atherosclerosis       Date:  2011-10-02       Impact factor: 5.162

3.  Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.

Authors:  Hong Lu; Anju Balakrishnan; Deborah A Howatt; Congqing Wu; Richard Charnigo; Gene Liau; Lisa A Cassis; Alan Daugherty
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.

Authors:  Karin Tran-Lundmark; Phan-Kiet Tran; Gabrielle Paulsson-Berne; Vincent Fridén; Raija Soininen; Karl Tryggvason; Thomas N Wight; Michael G Kinsella; Jan Borén; Ulf Hedin
Journal:  Circ Res       Date:  2008-07-03       Impact factor: 17.367

5.  NMR-based metabolomics of urine for the atherosclerotic mouse model using apolipoprotein-E deficient mice.

Authors:  Gregory C Leo; Andrew L Darrow
Journal:  Magn Reson Chem       Date:  2009-12       Impact factor: 2.447

6.  Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J Mice.

Authors:  Lakshmi Narasimha Rao; Thiruvelselvan Ponnusamy; Sheena Philip; Rupak Mukhopadhyay; Vijay V Kakkar; Lakshmi Mundkur
Journal:  Lipids       Date:  2015-07-16       Impact factor: 1.880

7.  The western-type diet induces anti-HMGB1 autoimmunity in Apoe(-/-) mice.

Authors:  Yue Pan; Hanzhong Ke; Zhaoqi Yan; Yajun Geng; Nathan Asner; Sunil Palani; Gnanasekar Munirathinam; Subramanyam Dasari; Karin C Nitiss; Sarah Bliss; Priyanka Patel; Hongming Shen; Catherine A Reardon; Godfrey S Getz; Aoshuang Chen; Guoxing Zheng
Journal:  Atherosclerosis       Date:  2016-05-19       Impact factor: 5.162

8.  Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice.

Authors:  Reema Goel; Benjamin R Schrank; Shikha Arora; Brian Boylan; Barbara Fleming; Hiroto Miura; Peter J Newman; Robert C Molthen; Debra K Newman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

9.  IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages.

Authors:  Khatuna Gabunia; Stephen Ellison; Sheri Kelemen; Farah Kako; William D Cornwell; Thomas J Rogers; Prasun K Datta; Mireille Ouimet; Kathryn J Moore; Michael V Autieri
Journal:  Am J Pathol       Date:  2016-03-04       Impact factor: 4.307

10.  Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.

Authors:  Alan Daugherty; Debra L Rateri; Israel F Charo; A Phillip Owens; Deborah A Howatt; Lisa A Cassis
Journal:  Clin Sci (Lond)       Date:  2010-03-09       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.